Trophos initiates phase II proof of concept study for novel cardioprotective compound, TRO40303, in...
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation...
Hybrigenics’ specific inhibitor of Ubiquitin-Specific Protease 7 (USP7) is cytotoxic for chronic lymphocytic leukaemia...
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on...
Cytheris to present interim data from ECLIPSE II Hepatitis C multicenter study at AASLD...
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies...
TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg...
TxCell SA, a biotechnology company developing Treg cell-based immunotherapies for the treatment of severe...
Trophos hosts round-table meetings at ECTRIMS to design POC trial to treat progression in...
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation...
CertiVox wins prestigious 2011 Bully Awardsis
CertiVox, an information security company, today announces it has received the Yearling category of the...
Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research
Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the...
Rib-X Pharmaceuticals’ RX-04 Program Yields Compounds with In Vitro Potency Against Multi-drug Resistant P....
Rib-X Pharmaceuticals, Inc. announced that results from the Company's RX-04 development program will be...
Further European Regulatory Review Clarifies and Confirms Prior CHMP Position on Positive Benefit-Risk Balance...
Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the...
Cook Medical’s Zilver® PTX® Drug-Eluting Stent Technology Receives Unanimous Recommendation from FDA Advisory Committee
The Zilver® PTX® Drug-Eluting Stent, the first device of its kind developed to treat...
